Dr. Muaaz Tarabichi

Dr. Muaaz Tarabichi

Dr.Muaaz Tarabichi is a world-renowned Ear and Sinus Surgeon and the Co-Founder of Tarabichi Stammberger Ear and Sinus Institute (TSESI) in Dubai, UAE. The Institute is a group of ENT surgeons and healthcare research personnel whose sole mission is to improve the quality, safety, effectiveness, and cost of medical interventions in Ear and Sinus Surgery.

Dr. Tarabichi is a world-renowned Ear and Sinus Surgeon, and the Co-Founder of Tarabichi Stammberger Ear and Sinus Institute (TSESI) in Dubai UAE, the Institute is a group of ENT surgeons and healthcare research personnel whose sole mission is to improve the quality, safety, effectiveness, and cost of medical interventions in Ear and Sinus Surgery.

A pioneer in Endoscopic Ear and Sinus Surgery, for the last 30 years he has spearheaded and established groundbreaking and revolutionary medical techniques in the field, including the Tarabichi Stitch for Endoscopic Ear Surgery, as well as the Eustachian Tuboplasty Technique known as Endoscopic Transtympanic Eustachian Tube Dilatation. Endoscopic transtympanic Eustachian tube dilation was first truly pioneered by Muaaz Tarabichi, MD, in Dubai during the late 1990s. He is credited with developing and implementing this technique, which is a surgical approach to dilate the Eustachian tube through the eardrum using an endoscope.

His contributions have led to him being recognized as the β€œFather of Endoscopic Ear Surgery”. While the Eustachian tube itself was first described by Bartholomaeus Eustachius in the 16th century, the specific technique of endoscopic transtympanic dilation is attributed to Muaaz Tarabichi. This technique allows surgeons to visualize and dilate the Eustachian tube, which can help with various ear problems, including chronic ear infections and Eustachian tube dysfunction.

Advanced Sinus Surgery Innovations

Building on his extensive experience in endoscopic sinus surgery, Dr. Tarabichi developed EverOpen+ Advance Sinus Surgery as a structured, outcome-driven approach to reduce post-surgical sinus recurrence. Sinus disease often returns due to persistent inflammation, scar tissue formation, or narrowing of the sinus openings during healing, even after successful surgery. Chronic infection and allergies can also contribute to recurrence.
EverOpen+ Advance Sinus Surgery uses a drug-releasing implant placed after surgery to deliver localized anti-inflammatory medication directly into the sinus cavity. This helps maintain sinus openness, reduce inflammation, and minimize scar formation, significantly lowering recurrence rates and improving long-term surgical success.
He also established the Sinus Link Network, a collaborative professional initiative focused on advancing sinus surgery standards, enhancing surgeon training, and promoting evidence-based surgical protocols to improve clinical consistency and patient outcomes across international ENT practice.

Credentials & Qualifications

CLINICAL EXPERTISE AND SERVICES OFFERED

Book Your Visit

Fill out the form below to request an appointment. Our team will get back to you promptly.








    Frequently Asked Questions

    Am I a good candidate for EverOpen+ Advance Sinus Surgery?

    Patients with chronic sinusitis who continue to experience symptoms despite medication or previous sinus surgery may be candidates. A detailed ENT evaluation and endoscopic examination are required to confirm suitability.

    The procedure is performed under anesthesia, so there is no pain during surgery. Mild discomfort, nasal congestion, or pressure may occur during the early healing period and usually improve within a few days.Β 

    Sinus surgery with EverOpen+Β  typically takes between 30 to 90 minutes, depending on the severity and complexity of the sinus condition.Β 

    Sinus recurrence can happen due to ongoing inflammation, allergic triggers, infection, or natural healing processes that lead to scar tissue formation and narrowing of sinus openings. Even after successful surgery, these factors can cause symptoms to return.Β 

    EverOpen+ uses a bio-absorbable, drug-eluting implant placed inside the sinus after surgery. It delivers targeted anti-inflammatory medication directly to the surgical site, keeps sinus passages open during healing, reduces scar formation, and significantly lowers the risk of recurrence

    Yes, in many cases patients may still require saline rinses, nasal sprays, or allergy management to support long-term healing and prevent inflammation from returning.

    While no treatment can guarantee 100% prevention, EverOpen+ significantly reduces recurrence rates and improves long-term surgical success compared to conventional healing methods.Β 

    Unlike standard surgery that only clears blocked sinus pathways, EverOpen+Β  Advanced sinus surgery actively manages healing by controlling inflammation and scarring from inside the sinus, improving long-term outcomes and reducing the need for revision surgery.Β 

    CONSULTANT OTOLARYNGOLOGIST | EVEROPEN+ DEVELOPER

    Dr. Muaaz Tarabichi

    Consultant Otolaryngologist (ENT Specialist) | Developer of EverOpen+

    Dr. Muaaz Tarabichi is a consultant otolaryngologist with experience in endoscopic ear and sinus surgery, surgical innovation, and medical education.

    He developed EverOpen+, an advanced sinus surgery approach combining endoscopic treatment with a dissolvable drug-releasing implant designed to manage postoperative inflammation and help reduce recurring sinus blockage.

    Consultant Otolaryngologist Endoscopic Sinus Surgery EverOpen+ Developer
    Dr. Muaaz Tarabichi, Consultant Otolaryngologist and developer of EverOpen+
    Dr. Muaaz Tarabichi
    Consultant Otolaryngologist
    ABOUT DR. MUAAZ TARABICHI

    Expertise in Endoscopic Sinus Surgery

    Dr. Muaaz Tarabichi has contributed to endoscopic ENT surgery through clinical practice, surgical innovation, and specialist education.

    His experience includes endoscopic sinus surgery, endoscopic ear surgery, and the development of treatment approaches focused on improving surgical outcomes and postoperative care.

    ADVANCING SINUS CARE

    The Innovation Behind EverOpen+

    EverOpen+ was developed by Dr. Muaaz Tarabichi to improve affected sinus drainage pathways while addressing inflammation during recovery.

    The approach combines endoscopic sinus surgery with a dissolvable drug-releasing implant that delivers anti-inflammatory medication directly into the treated area.

    The implant gradually dissolves in approximately 45–60 days, helping manage postoperative swelling and support improved sinus drainage.

    This combined approach may help reduce the likelihood of sinus blockage returning.

    The EverOpen+ Approach

    Endoscopic Sinus Surgery

    Improves affected sinus drainage pathways.

    Drug-Releasing Implant

    Delivers anti-inflammatory medication directly to the treated area.

    45–60-Day Dissolution

    The implant gradually dissolves during recovery.

    CLINICAL EXPERIENCE

    Areas of Expertise

    01

    Endoscopic Sinus Surgery

    02

    Endoscopic Ear Surgery

    03

    Stapedotomy and Tympanoplasty

    04

    Drug-Releasing Sinus Implant Technology

    05

    ENT Surgical Innovation and Medical Education

    Professional Contributions

    EverOpen+ Developer

    Developed an advanced sinus surgery approach combining endoscopic treatment and postoperative inflammation management.

    Tarabichi Stammberger Ear and Sinus Institute (TSESI)

    Professional involvement in specialist education and endoscopic surgical training.

    Sinus Link Network

    Supports education and professional collaboration related to EverOpen+ and advanced sinus care.

    PATIENT QUESTIONS

    Frequently Asked Questions

    Who is Dr. Muaaz Tarabichi?

    Dr. Muaaz Tarabichi is a consultant otolaryngologist and the developer of EverOpen+, with experience in endoscopic ear and sinus surgery.

    What is EverOpen+?

    EverOpen+ combines endoscopic sinus surgery with a dissolvable drug-releasing implant to help manage inflammation during postoperative recovery.

    Why was EverOpen+ developed?

    The approach was developed to address sinus drainage and postoperative inflammation together, helping reduce the likelihood of recurring sinus blockage.

    How long does the EverOpen+ implant take to dissolve?

    The implant gradually dissolves in approximately 45–60 days.

    How can I request a consultation?

    Submit an enquiry through the Resolved Sinus website for information about available consultations and appointment arrangements.

    Consultation & Support

    Let's Discuss Your Sinus Care Options

    Experiencing persistent or recurring sinus symptoms? Learn more about EverOpen+ Advanced Sinus Surgery and available ENT consultation options in Abu Dhabi.

    Contact Our Team

    Enquire about EverOpen+, participating ENT specialists and consultation availability.

    Phone Enquiries

    Contact our team for assistance with consultation enquiries and treatment information.

    Location

    NMC Royal Hospital, Abu Dhabi, UAE.

    Request a Consultation

    Complete the form below and our team can contact you regarding available consultation options.